| Psoriatic Arthritis |
1 |
1 |
| Arthritis |
0 |
0.83 |
| Rheumatoid Arthritis |
0 |
0.99 |
| Spondylitis, Spondylosis, Kyphosis |
0 |
0.68 |
| Thromboembolism |
0 |
0.39 |
| Food and Drug Administration (FDA) |
0 |
0.98 |
| Otolaryngology |
0 |
0.28 |
| Cerebrovascular Accident |
0 |
0.24 |
| Pulmonary Embolism |
0 |
0.23 |
| Thrombosis |
0 |
0.23 |
| Dermatitis |
0 |
0.22 |
| Deep Venous Thrombosis |
0 |
0.18 |
| Atopic Dermatitis |
0 |
0.15 |
| Europe |
0 |
0.15 |
| Fatigue |
0 |
0.15 |
| Vasculitis |
0 |
0.13 |
| Anti-Tumor Necrosis Factor (Anti-TNF) |
0 |
0.11 |
| Cardiovascular Risk Management |
0 |
0.11 |
| Crohn Disease |
0 |
0.11 |
| Psoriasis |
0 |
0.11 |
| Upper Respiratory Tract Infection |
0 |
0.11 |
| Ulcerative Colitis |
0 |
0.09 |
| Adolescent Medicine |
0 |
0.07 |
| Ankylosing Spondylitis |
0 |
0.07 |
| Blood |
0 |
0.07 |
| Chronic Disease |
0 |
0.07 |
| Colitis |
0 |
0.07 |
| Disability |
0 |
0.07 |
| Embolism |
0 |
0.07 |
| Giant Cell Arteritis |
0 |
0.07 |
| Infarction |
0 |
0.07 |
| Lymphoma |
0 |
0.07 |
| Plaque Psoriasis |
0 |
0.07 |
| Prostate Specific Antigen |
0 |
0.07 |
| Respiratory Tract |
0 |
0.07 |
| Takayasu Arteritis |
0 |
0.07 |
| Tumor |
0 |
0.07 |
| Biologic Therapy |
0 |
0.06 |
| Herpes Simplex |
0 |
0.06 |
| Herpes Zoster |
0 |
0.06 |
| Inflammatory Bowel Disease |
0 |
0.06 |
| Myocardial Infarction (MI) |
0 |
0.06 |
| Prostate Cancer |
0 |
0.06 |